Mayer, Mark Canedo, Angelica Dinh, Tam Low, Madelyn Ortiz, Ariel Garay, Chloé Supplemental Material, 812778_supplemental_appendices - Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views <p>Supplemental Material, 812778_supplemental_appendices for Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views by Mark Mayer, Angelica Canedo, Tam Dinh, Madelyn Low, Ariel Ortiz, and Chloé Garay in Therapeutic Innovation & Regulatory Science</p> artificial intelligence;regulatory intelligence;precompetitive consortia 2018-12-06
    https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_812778_supplemental_appendices_-_Potential_Use_of_Artificial_Intelligence_for_Regulatory_Intelligence_Biopharmaceutical_Industry_s_Views/7454810
10.25384/SAGE.7454810.v1